A case of cardiac sarcoidosis occurring during combination therapy by IFN α and ribavirin for chronic hepatitis C

Journal of Japanese Society of Gastroenterology

Volumn 107, Issue 8, 2010, Pages 1319-1327

  Iwashita, Masahide ^b   Maeda, Teruo ^b   Tagami, Atsushi ^b   Watanabe, Naoki ^b   Takada, Jun ^b   Asano, Takahiko ^b   Hatakeyama, Hiroo ^b   Hayashi, Takao ^b   Nishiwaki, Shinji ^b   Saito, Koshiro ^a  

^a Nishimino Kosei Hospital   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID DERIVATIVE; RIBAVIRIN; ANTIVIRUS AGENT;

AGED; ARTICLE; BIOPSY TECHNIQUE; CASE REPORT; CLINICAL EXAMINATION; COMPLETE HEART BLOCK; DISEASE COURSE; DRUG ERUPTION; DRUG WITHDRAWAL; FEMALE; HEART SARCOIDOSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; LYMPHADENOPATHY; PACEMAKER; SARCOIDOSIS; TREATMENT DURATION; TREATMENT OUTCOME; UVEITIS; CARDIOMYOPATHIES; HEPATITIS C, CHRONIC;

AGED; ANTIVIRAL AGENTS; CARDIOMYOPATHIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; RIBAVIRIN; SARCOIDOSIS;

EID: 77955912876     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Eishi Y, Ishige I, Ishige Y, et al: Etiology of sarcoidosis: the role of Propionibacterium acne. Acta Histochem Cytochem 36; 15-26: 2003 (Pubitemid 36548487)
2. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7; 145-173: 1989
3. Walker C, Bauer W, Braun RK, et al: Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 150; 1038-1048: 1994 (Pubitemid 24318033)
4. Moller DR, Forman JD, Liu MC, et al: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 156; 4952-4960: 1996
5. Shigehara K, Shijubo N, Ohmichi M, et al: Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis. Clin Exp Immunol 132; 152-157: 2003 (Pubitemid 36418918)
6. Shibuya H, Nagai T, Ishii A, et al: Differential regulation of Th1 responses and CD154 expression in human CD4 + T cells by IFN-alpha. Clin Exp Immunol 132; 216-224: 2003 (Pubitemid 36560615)
7. Sareneva T, Julkunen I, Matikainen S: IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J Immnuol 165; 1933-1938: 2000
8. Matikainen S, Paananen A, Miettinen M, et al: IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur J Immunol 31; 2236-2245: 2001 (Pubitemid 32640741)
9. Shiftman ML, Ghany MG, Morgan TR, et al: Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. Gastroenterology 132; 103-112: 2007
10. Nakajima M, Kubota Y, Miyashita N, et al: Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Intern Med 35; 376-379: 1996 (Pubitemid 26229087)
11. Teragawa H, Hondo T, Takahashi K, et al: Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med 35; 19-23: 1996 (Pubitemid 26113130)
12. Nawras A, Alsolaiman MM, Mehboob S, et al: Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci 47; 1627-1631: 2002 (Pubitemid 34753946)
13. Papaioannides D, Fotinou M, Korantzopoulos P, et al: Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. Med Sci Monit 10; CS5-CS7: 2004
14. Salvio A, Mormile M, Giannattasio F, et al: Pulmonary sarcoidosis during interferon therapy: a rare or underestimated event? Ann Ital Med Int 19; 58-62: 2004
15. Butnor KJ: Pulmonary sarcoidosis induced by interferon-alpha therapy. Am J Surg Pathol 29; 976-979: 2005
16. Farah R, Farah R, Makhoul N: Interferon-induced pulmonary sarcoidosis. Int J Clin Pharmacol Ther 43; 441-443: 2005
17. Bolukbas C, Bolukbas FF, Kebdir T, et al: Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C-A case report and review of the literature. Acta Gastroenterol Belg 68; 432-434: 2005 (Pubitemid 43067246)
18. Tebben PJ, Atkinson JL, Scheithauer BW, et al: Granulomatous adenohypophysitis after interferon and ribavirin therapy. Endocr Pract 13; 169-175: 2007
19. Doycheva D, Deuter C, Stuebiger N, et al: Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol 247; 675-680: 2009